Onco.com Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Onco.com's estimated annual revenue is currently $101.6M per year.(i)
  • Onco.com's estimated revenue per employee is $337,500

Employee Data

  • Onco.com has 301 Employees.(i)
  • Onco.com grew their employee count by 8% last year.

Onco.com's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2392.4M632922%N/AN/A
#2
$5M363%N/AN/A
Add Company

What Is Onco.com?

At Onco.com, we are building a virtual cancer hospital for the world. Through our network of world-class oncologists, our mission is to provide accurate, unbiased consults to cancer patients at every stage of their disease so that they can take the right decisions.

keywords:N/A

N/A

Total Funding

301

Number of Employees

$101.6M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Onco.com News

2022-04-19 - Oncopeptides publishes the 2021 Annual Report | | news ...

... is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO. More information is available on www.oncopeptides.com.

2022-04-19 - Oncopeptides publishes the 2021 Annual Report

STOCKHOLM, April 21, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) ... More information is available on www.oncopeptides.com.

2022-04-13 - Bioinformatics Approach helps Optimizes the Selection of ...

The Onco'Zine Brief ... The Onco'Zine Dossier ... (PRWeb April 19, 2022)Read the full story at https://www.prweb.com/releases/...

2019-09-28 - Cancer care platform Onco.com raises $7 million

Onco.com Onco.com Founded: 2017 Headquarters: Bangalore, India Total Funding: $8.5M See full company profile "> , India’s only internet aggregator for cancer care, announced completion of $7 million in series A funding by Accel, Chiratae Venture (earlier known as IDG Ventures) and Dream Incu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$103.5M301-12%N/A
#2
$52.7M301-31%N/A
#3
$54.7M30221%N/A
#4
$42.6M30410%N/A
#5
$102.6M30474%N/A
OSZAR »